ANAPC4 Antikörper (N-Term)
Kurzübersicht für ANAPC4 Antikörper (N-Term) (ABIN1731762)
Target
Alle ANAPC4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Reacts with human ANAPC4
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- 14 amino acid peptide near the amino terminus of human APC4.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: ELISA, IHC - P (5 μg/mL), WB (1 - 2 μg/mL)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.02 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted.
-
-
- ANAPC4 (Anaphase Promoting Complex Subunit 4 (ANAPC4))
-
Andere Bezeichnung
- ANAPC4 / APC4
-
Hintergrund
- Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains.
-
UniProt
- Q9UJX5
-
Pathways
- M Phase
Target
-